Setting Up the Analysis
To evaluate GMP accuracy, we need a consistent methodology: compare pre-listing GMP (taken the evening before listing day) against the actual opening price on the day of listing. This is the most practically useful comparison because it answers the question an investor with allotment faces: "Should I sell immediately on listing or hold?"
Broad analysis of Indian mainboard IPOs from 2021–2025 across multiple market cycles shows a nuanced picture — GMP is neither perfectly accurate nor random noise.
Accuracy in Bull Markets
During bull market periods (late 2021, mid-2023, 2024), GMP accuracy was high. For IPOs with pre-listing GMP of 20–50%, actual opening prices matched GMP within ±8% in roughly 72% of cases. Several factors drove this accuracy:
- Stable broader markets reduced listing-day volatility
- Strong retail participation meant grey market operators had good read on demand
- IPOs were uniformly well-subscribed, validating operator pricing models
Accuracy in Volatile Markets
During volatile periods (early 2022 correction, late 2024 FII outflows), GMP accuracy deteriorated sharply. In some periods, fewer than 50% of IPOs listed within ±15% of their GMP. The pattern of failures was consistent: positive GMP IPOs listed well below expectation when market conditions deteriorated between allotment and listing.
The key insight: GMP accuracy is not a fixed characteristic of the indicator — it varies with market regime. In trending markets, trust GMP more. In volatile markets with rapid sentiment shifts, apply wider confidence intervals.
The Systematic Bias: GMP Overestimates on High-NII IPOs
The most consistent bias in GMP: for IPOs with extremely high NII (HNI) oversubscription (100x+), GMP systematically overestimates listing performance. The mechanism is clear: HNIs who borrowed ₹10–50 crore to apply in the NII category have high interest costs and are forced to sell immediately on listing regardless of price. This selling pressure — multiplied across hundreds of HNIs with the same constraint — depresses the opening price below the GMP-implied level.
Practical rule: when NII oversubscription is above 100x, discount pre-listing GMP by 20–30% to get a more realistic opening price estimate.
GMP Accuracy for SME IPOs
SME IPO GMP is less reliable than mainboard GMP. The thinner grey market means individual operator preferences can dominate price discovery. Analysis suggests SME GMP is accurate within ±20% in about 55–60% of cases — meaningfully less accurate than mainboard. However, in the minority of SME IPOs with clear genuine demand (verified by strong, broad-based subscription and reputable anchor investors), SME GMP accuracy approaches mainboard levels.
GMPIpoWatch publishes listing outcome data alongside GMP history, allowing you to evaluate accuracy for any past IPO directly — an essential tool for calibrating how much to trust current GMP signals.
Loading comments...